- $5.11bn
- $9.45bn
- $4.15bn
- 58
- 86
- 42
- 65
Annual income statement for Bausch + Lomb, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,778 | 3,412 | 3,765 | 3,768 | 4,146 |
| Cost of Revenue | |||||
| Gross Profit | 2,451 | 2,127 | 2,298 | 2,249 | 2,504 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,382 | 3,152 | 3,436 | 3,561 | 4,016 |
| Operating Profit | 396 | 260 | 329 | 207 | 130 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 399 | 290 | 318 | 73 | -166 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 303 | -17 | 193 | 15 | -248 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 298 | -18 | 182 | 6 | -260 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 298 | -18 | 182 | 6 | -260 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.938 | -0.035 | 0.543 | 0.09 | -0.588 |
| Dividends per Share |